ReviewThe Kaohsiung journal of medical sciences2026
Heterogeneity Analyzed by CT-Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review.
Review in The Kaohsiung journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Tumors are highly heterogeneous, and whole-lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction. However, there is no spatial information for understanding which components provide the most critical information. Recently, habitat analysis has gained widespread attention, and it is used to divide a tumor into distinct sub-regions, called habitats, that share common characteristics. CT reveals heterogeneity in attenuation, texture, entropy, and enhancement patterns, which can be used to generate habitats. In the past 2 years, many studies exploring the role of CT habitats have been reported. The divided habitats can be used to build models for the classification of histological or molecular subtypes, the evaluation and prediction of treatment response, and prognostication of progression-free survival or overall survival. This review aims to summarize studies on the application of CT-habitat analysis for cancer management. In addition to clinical applications, various methods for habitat segmentation will be reviewed. Lastly, how spatial information revealed by the habitat can guide tissue biopsy for tissue-level confirmation studies will be described, which is critical for understanding the underlying biology and paving the way for future clinical implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.